Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. vaccination candidate
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Videos

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Africa
  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Business Types

  • Manufacturer
  • Technology
Industries served

  • Medical / Health Care

Vaccination Candidate Suppliers & Manufacturers

36 companies found

Helix Nanotechnologies, Inc.

Helix Nanotechnologies, Inc.

based inCambridge, MASSACHUSETTS (USA)
mRNA gives scientists superpowers. Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can ...
CONTACT SUPPLIER

Moderna, Inc.

Moderna, Inc.

based inCambridge, MASSACHUSETTS (USA)
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. ...
CONTACT SUPPLIER

BlueWillow Biologics

BlueWillow Biologics

based inAnn Arbor, MICHIGAN (USA)
BlueWillow Biologics is a clinical-stage, privately-held biopharmaceutical company focused on developing and commercializing intranasal vaccines using its patented nanoemulsion platform. The platform, originally discovered at the University of ...
BlueWillow - Herpes Simplex Virus-2 Vaccine  (HSV-2)

BlueWillow - Herpes Simplex Virus-2 Vaccine (HSV-2)

Herpes simplex virus-2 (HSV-2) is the leading cause of genital herpes, a sexually transmitted disease affecting over 500 million people worldwide. BlueWillow’s intranasal nanoemulsion (NE) vaccine is uniquely suited to offer protection against ...
CONTACT SUPPLIER

SpyBiotech Limited

SpyBiotech Limited

based inOxford, UNITED KINGDOM
Utilising unique protein superglue technology to develop vaccines against infectious disease and cancer worldwide. SpyBiotech came into being to change that. Our pioneering technology, the proprietary protein superglue SpyTag/SpyCatcher, enables us ...
CMV or Human Cytomegalovirus

CMV or Human Cytomegalovirus

CMV is the most common virus that most people have never heard of, even though it has now been identified as a high priority for vaccines development by key authorities such as the FDA and Institute of ...
CONTACT SUPPLIER

Ocugen, Inc.

Ocugen, Inc.

based inMalvern, PENNSYLVANIA (USA)
Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19. Our breakthrough modifier gene therapy platform ...
CONTACT SUPPLIER

Auro Vaccines LLC

Auro Vaccines LLC

based inPearl River, NEW YORK (USA)
Auro Vaccines LLC is a clinical-stage vaccine development company pioneering a major evolutionary step in the design and development of preventive and therapeutic vaccines for infectious diseases. Our novel approach is based on a proprietary ...
Auro - Model PBS VAX - Preclinical-Stage Therapeutic Vaccines for HBV

Auro - Model PBS VAX - Preclinical-Stage Therapeutic Vaccines for HBV

Auro Vaccines has also developed a GeneVax prime/VesiculoVax boost therapeutic vaccine that targets all eight HBV genotypes for use as an adjunct to drug ...
CONTACT SUPPLIER

Ocean Biomedical

Ocean Biomedical

based inProvidence, RHODE ISLAND (USA)
Ocean Biomedical is a 21st century biopharma company that partners with leading scientists and research institutions to accelerate the translation of new discoveries into breakthrough medicines. We're working to bring together the interdisciplinary ...
CONTACT SUPPLIER

Angany Inc.

Angany Inc.

based inSt-Jean, QUEBEC (CANADA)
We are an innovative pharmaceutical company determined to improve the lige of people with allergy. We have developed our biotechnology with you in mind. How could we turn on sharp insights on allergy and precision medicine into a better life for ...
COVID-19 Novel Vaccination Technology

COVID-19 Novel Vaccination Technology

ANGANY is joining the COVID-19 effort with its promising novel vaccination technology. The unprecedented social and economic upset caused by the pandemic called for social responsibility. ANGANY’s entire team pitched in to join the fight! The ...
CONTACT SUPPLIER

EnGen Bio LLC

EnGen Bio LLC

based inREDWOOD CITY, CALIFORNIA (USA)
EnGen Bio is developing a therapy and vaccine to provide lifetime immunity to Type A flu. We´ve discovered influenza´s ¨Achille´s heel¨ Unlike conventional flu vaccines, which are generally hemagglutinin or whole-virus based, our vaccine targets a ...
CONTACT SUPPLIER

FluGen, Inc.

FluGen, Inc.

based inMadison, WISCONSIN (USA)
FluGen, Inc. is developing a more effective vaccine in the fight against influenza and respiratory disease. The M2SR Vaccine Platform has the potential to revolutionize the $5 billion annual influenza market, with a clinically-tested vaccine ...
FluGen - Model M2SR - Single Replication Live Virus Vaccine

FluGen - Model M2SR - Single Replication Live Virus Vaccine

The M2 Deleted Single Replication Live Virus Vaccine (M2SR) offers a potentially differentiating clinical value proposition. FluGen’s flu vaccine candidate works differently, stimulating ...
CONTACT SUPPLIER

OncoVITA

OncoVITA

based inParis, FRANCE
Oncovita is a biotech company developing a disruptive virus-derived vaccine technology to treat multiple types of cancers. Our MeasovirTM platform was developed based on the safe and highly immunogenic measles virus vaccine, a vaccine with ...
CONTACT SUPPLIER

VBI Vaccines Inc.

VBI Vaccines Inc.

based inCambridge, MASSACHUSETTS (USA)
VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP ...
CONTACT SUPPLIER

Vaxdyn, S. L.

Vaxdyn, S. L.

based inDos Hermanas (Sevilla), SPAIN
Vaxdyn was founded in 2011 as a spin-off established by researchers of the Institute of Biomedicine of Seville, a center of the Andalusian Public Health System and the University of Seville linked to the University Hospital Virgen del Rocío of ...
CONTACT SUPPLIER

AstraZeneca

AstraZeneca

based inCambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
Icosavax - Model IVX-421 - SARS-CoV-2 Beta (B.1.351) Variant VLP Vaccine Candidate

Icosavax - Model IVX-421 - SARS-CoV-2 Beta (B.1.351) Variant VLP Vaccine Candidate

Icosavax has initiated development of IVX-421, a SARS-CoV-2 vaccine candidate that incorporates an RBD antigen with critical mutations found in the SARS-CoV-2 beta ...
CONTACT SUPPLIER

Scandinavian Biopharma

Scandinavian Biopharma

based inSolna, SWEDEN
We are developing the first vaccine for protection against diarrhoea caused by ETEC in travellers, military, health care personnel and endemic populations with a key focus on the most vulnerable – children under five years of age in Low- and ...
Research & Development Services

Research & Development Services

Our development is mainly focused on developing the first vaccine in the world against Enterotoxigenic Escherichia Coli (ETEC) induced diarrhoea. Our vision is to develop an ETEC vaccine with the potential of saving hundreds of thousand lives and ...
CONTACT SUPPLIER

BioDiem Ltd.

BioDiem Ltd.

based inSouth Melbourne, AUSTRALIA
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our business model is to generate income from partnerships including with other vaccine and infectious ...
Biodiem - Model LAIV - Live Attenuated Influenza Virus Vaccine

Biodiem - Model LAIV - Live Attenuated Influenza Virus Vaccine

A core technology advantage: Live Attenuated Influenza Virus (LAIV) vaccine. BioDiem’s lead asset is the Live Attenuated Influenza Virus (LAIV) vaccine technology. Our LAIV vaccine licensing business involves out-licensing of the ...
CONTACT SUPPLIER

ARTES Biotechnology GmbH

ARTES Biotechnology GmbH

based inLangenfeld, GERMANY
ARTES Biotechnology is a globally working, well established and reliable technology provider for recombinant protein production. We develop microbial cell lines and processes for vaccines, biopharmaceuticals, biosimilars and enzymes and offer ...
CONTACT SUPPLIER

CanVirex AG

CanVirex AG

based inBasel, SWITZERLAND
CanVirex is a spin-off from the Heidelberg University Hospital, founded in 2017 in Basel, Switzerland. The company develops novel immunotherapeutics for the treatment of cancer and has recently committed to using its unique technology to develop a ...
CONTACT SUPPLIER

CuraVac Europe S.A.

CuraVac Europe S.A.

based inRixensart, BELGIUM
CuraVac is a clinical-stage biotech company developing the medical and commercial potential of a revolutionary technique for the production of specific Therapeutic Vaccines for the treatment of autoimmune diseases. The company was founded by a ...
CuraVac MYASTERIX - Therapeutic Vaccine

CuraVac MYASTERIX - Therapeutic Vaccine

The MYASTERIX project (2013 – 2018) advanced a Therapeutic Vaccine candidate (designated orphan drug) indicated for myasthenia gravis (MG) to clinical proof of concept ...
CONTACT SUPPLIER

Novavax

Novavax

based inGaithersburg, MARYLAND (USA)
We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. We have more than a decade of experience contending with ...
NanoFlu - Seasonal Influenza

NanoFlu - Seasonal Influenza

In March 2020, we announced positive top-line results from our Phase 3 clinical trial of our nanoparticle seasonal quadrivalent influenza vaccine candidate, including our proprietary Matrix-M™ adjuvant ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT